{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:52Z","timestamp":1790713792983,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nbd.2019.104513","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T17:07:04Z","timestamp":1561136824000},"page":"104513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Kasey L.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monyrath","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S.","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-3677","authenticated-orcid":false,"given":"S. Pablo","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2019.104513_bb0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000158","article-title":"Previously unrecognized behavioral phenotype in Gaucher disease type 3","volume":"3","author":"Abdelwahab","year":"2017","journal-title":"Neurol. Genet."},{"issue":"5","key":"10.1016\/j.nbd.2019.104513_bb0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.nbd.2019.104513_bb0015","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.008185","article-title":"Animal models for Gaucher disease research","volume":"4","author":"Farfel-Becker","year":"2011","journal-title":"Dis. Model. Mech."},{"issue":"9645","key":"10.1016\/j.nbd.2019.104513_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.nbd.2019.104513_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.nbd.2019.104513_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","article-title":"Viral vectors for gene delivery to the central nervous system","volume":"48","author":"Lentz","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104513_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2016.10.011","article-title":"Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients","volume":"68","author":"Machaczka","year":"2018","journal-title":"Blood Cell Mol. Dis."},{"issue":"3","key":"10.1016\/j.nbd.2019.104513_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-010-9072-z","article-title":"Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy","volume":"33","author":"Marshall","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2019.104513_bb0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/mt.2016.53","article-title":"CNS-accessible inhibitor of glucosylceramide synthase for substrate reduction therapy of Neuronopathic Gaucher disease","volume":"24","author":"Marshall","year":"2016","journal-title":"Mol. Ther."},{"issue":"13","key":"10.1016\/j.nbd.2019.104513_bb0050","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.nbd.2019.104513_bb0055","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type 1 Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.nbd.2019.104513_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/00006450-200008000-00018","article-title":"Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation","volume":"48","author":"Orvisky","year":"2000","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.nbd.2019.104513_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.nbd.2019.104513_bb0070","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","volume":"77","author":"Passini","year":"2003","journal-title":"J. Virol."},{"issue":"72","key":"10.1016\/j.nbd.2019.104513_bb0075","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.nbd.2019.104513_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-4886(78)90145-0","article-title":"Electrode placement and kindling-induced experimental epilepsy","volume":"58","author":"Pinel","year":"1978","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2019.104513_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2019.104513_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diseases5010010","article-title":"The Spectrum of neurological manifestations associated with Gaucher disease","volume":"5","author":"Roshan Lal","year":"2017","journal-title":"Diseases"},{"issue":"2","key":"10.1016\/j.nbd.2019.104513_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cell Mol. Dis."},{"issue":"29","key":"10.1016\/j.nbd.2019.104513_bb0100","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.nbd.2019.104513_bb0105","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2019.104513_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejmhg.2016.02.001","article-title":"Treatment options for patients with Gaucher disease","volume":"17","author":"Shawky","year":"2016","journal-title":"Egypt. J. Med. Human Genet."},{"key":"10.1016\/j.nbd.2019.104513_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/374367a0","article-title":"Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain","volume":"374","author":"Snyder","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nbd.2019.104513_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.nbd.2019.104513_bb0125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611930172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611930172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:10Z","timestamp":1760851090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611930172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":25,"alternative-id":["S096999611930172X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104513","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104513"}}